Australia-based radiopharmaceutical company Telix Pharmaceuticals has created a new radionuclide generator that could facilitate the commercial supply of lead-212 isotope-based therapies. The company ...
BERLIN, Germany - (NewMediaWire) - August 5, 2024 - Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler) has received approval from the European Commission (EC) for its Ge-68/Ga-68 radionuclide ...
The issuer is solely responsible for the content of this announcement. August 5, 2024 - Berlin - Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler) has received approval from the European Commission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback